IMMUNOGLOBULIN E
Report
- Report Number
- 1823260-2015-01504
- Event Type
- Malfunction
- Date Received
- February 24, 2015
- Date of Event
- February 9, 2015
- Report Date
- April 15, 2015
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JHR
- PMA / PMN Number
- K061970
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
A SAMPLE FROM THE PATIENT WAS INVESTIGATED AND THE CUSTOMER'S RESULTS WERE CONFIRMED. THE PATIENT WAS INJECTED WITH XOLAIR (OMALIZUMAB, ANTI-HUMAN IGE ANTIBODY, NOVARTIS) FOR "RUSH ORAL IMMUNOTHERAPY."
ADDITIONAL INFORMATION WAS PROVIDED CONCERNING THE PATIENT. THE PATIENT'S HEIGHT WAS (B)(6). THE PATIENT WAS TAKING 300 MG/DAY OF XOLAIR ONCE EVERY TWO WEEKS FROM (B)(6) 2014 THROUGH CURRENT DAY.
AS PART OF THE INVESTIGATION, XOLAIR WAS ADDED TO HUMAN IGE SAMPLES AND THE RESULTS COMPARED WITH A DRUG FREE CONTROL SAMPLE. THE SPIKED SAMPLES SHOWED REDUCED RECOVERY OF IGE. A PHARMACOLOGICAL INTERFERENCE WITH THE ASSAY WAS CONFIRMED.
THIS EVENT OCCURRED IN (B)(6).
THE CUSTOMER RECEIVED QUESTIONABLE IMMUNOGLOBULIN (IGE) RESULTS FOR ONE PATIENT SAMPLE FROM AN UNKNOWN ROCHE ANALYZER. ORIGINAL FIRST RESULT WAS 1701.0 IU/ML, REPEAT RESULT WAS 1799.0 IU/ML. AUTO DILUTION 1:5 RESULT WAS 938.4 IU/ML (CALCULATED 4692.0 IU/ML). AUTO DILUTION 1:10 RESULT WAS 509.8 IU/ML (CALCULATED 5098.0 IU/ML). MANUAL DILUTION 1:50 RESULT WAS 113.8 IU/ML (CALCULATED 5690 IU/ML). INFORMATION CONCERNING WHICH RESULT WAS REPORTED OUTSIDE THE LABORATORY OR IF THE PATIENT WAS ADVERSELY AFFECTED WAS REQUESTED, BUT WAS NOT PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 129743 | IMMUNOGLOBULIN E | RADIOIMMUNOASSAY, IMMUNOGLOBULINS (D, E) | JHR | ROCHE DIAGNOSTICS | NA | 175624 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 008 YR |